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Abstract
The Drk SH3-SH2-SH3 adaptor protein has been genetically identified in a screen for rate-limiting
components acting downstream of the Sevenless (Sev) receptor tyrosine kinase in the developing eye of
Drosophila. It provides a link between the activated Sev receptor and Sos, a guanine nucleotide release
factor that activates Ras1. We have used a combined biochemical and genetic approach to study the
interactions between Sev, Drk and Sos. We show that Tyr2546 in the cytoplasmic tail of Sev is required
for Drk binding, probably because it provides a recognition site for the Drk SH2 domain. Interestingly, a
mutation at this site does not completely block Sev function in vivo. This may suggest that Sev can
signal in a Drk-independent, parallel pathway or that Drk can also bind to an intermediate docking
protein. Analysis of the Drk-Sos interaction has identified a high affinity binding site for Drk SH3
domains in the Sos tail. We show that the N-terminal Drk SH3 domain is primarily responsible for
binding to the tail of Sos in vitro, and for signalling to Ras in vivo.
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The Drk SH3-SH2-SH3 adaptor protein has been
genetically identified in a screen for rate-limiting com-
ponents acting downstream of the Sevenless (Sev)
receptor tyrosine kinase in the developing eye ofDroso-
phila. It provides a link between the activated Sev
receptor and Sos, a guanine nucleotide release factor
that activates Rasl. We have used a combined bio-
chemical and genetic approach to study the interactions
between Sev, Drk and Sos. We show that Tyr2546 in
the cytoplasmic tail of Sev is required for Drk binding,
probably because it provides a recognition site for the
Drk SH2 domain. Interestingly, a mutation at this site
does not completely block Sev function in vivo. This
may suggest that Sev can signal in a Drk-independent,
parallel pathway or that Drk can also bind to an
intermediate docking protein. Analysis of the Drk-
Sos interaction has identified a high affinity binding
site for Drk SH3 domains in the Sos tail. We show
that the N-terminal Drk SH3 domain is primarily
responsible for binding to the tail of Sos in vitro, and
for signalling to Ras in vivo.
Key words: Drosophila/Sevenless/signal transduction/Sos/
SH2 adaptor protein/SH3 domain
Introduction
Receptor tyrosine kinases (RTKs) play an important role
in mediating the responses of cells to extracellular signals
during growth and differentiation of multicellular organ-
isms. Ligand-induced dimerization of receptors leads to
the activation of their kinase domain, and subsequent
autophosphorylation (Schlessinger and Ullrich, 1992). The
autophosphorylated receptor recruits a number of cyto-
plasmic proteins which contain a common sequence motif,
the SH2 (src-homology 2) domain (Koch et al., 1991;
Pawson and Gish, 1992). SH2 domains bind to specific
phosphotyrosine-containing peptide sequences (Songyang
et al., 1993; Marengere et al., 1994) and hence may
couple the stimulation of RTKs by their ligands to the
activation of different cytoplasmic signalling pathways.
Biochemical studies in mammalian systems and genetic
analysis in Drosophila and Caenorhabditis elegans have
indicated that one of these SH2 domain-containing
proteins, called Grb2 in mammals (Lowenstein et al.,
1992), Sem-5 in C.elegans (Clark et al., 1992) and Drk
in Drosophila (Olivier et al., 1993; Simon et al., 1993)
provides a functional link between RTKs and activation
of the Ras protein. The Sem-5/Grb2/Drk proteins contain
a single SH2 domain flanked by two SH3 (src-homology
3) domains. Binding of these polypeptides to autophos-
phorylated RTKs is mediated by the SH2 domain (Low-
enstein et al., 1992; Olivier et al., 1993). Grb2 and Drk
complex with the Ras guanine nucleotide exchange factor
Sos through binding of their SH3 domains -to proline-rich
motifs in Sos (Buday and Downward 1993; Egan et al.,
1993; Li et al., 1993; Olivier et al., 1993; Rozakis-Adcock
et al., 1993; Simon et al., 1993). Both genetic and
biochemical studies have shown that activation of Ras by
RTKs stimulates a conserved kinase cascade consisting of
Raf l, MAP kinase kinase (MAPKK) and MAP kinase
(MAPK) (for a recent review, see Marshall, 1994).
In Drosophila, mutations in drk impair signalling via
the Sevenless (Sev) receptor tyrosine kinase (Simon et al.,
1991, 1993; Olivier et al., 1993). The sev gene is expressed
in a subset of the 20 cells that give rise to the ommatidial
units of the compound eye (Tomlinson et al., 1987).
In the wild type, the initiation of photoreceptor cell
development in the R7 precursor cell is dependent on the
local activation of Sev by its ligand, the Boss protein,
which is expressed on the neighbouring R8 cell (Kramer
et al., 1991). In the absence of a functional Sev or Boss
protein, the R7 precursor cell differentiates as a non-
neural cone cell (Tomlinson and Ready, 1986; Reinke
and Zipursky, 1988). Conversely, if the Sev RTK is
constitutively activated by a mutation and overexpressed
in the same subset of cells as the wild-type protein, not
only the R7 precursor but also the cone cells initiate
neural development (Basler et al., 1991; Dickson et al.,
1992). The precursors of the R7 and the cone cells are
often referred to as the R7 equivalence group (Greenwald
and Rubin, 1992). The excess recruitment of R7 cells in
sev gain-of-function mutations, or the frequent loss of R7
cells in weak sev mutations, provide genetically sensitized
systems that have been used to screen for second-site
modifiers (Simon et al., 1991; Olivier et al., 1993; T.R.
and E.H., unpublished data). Loss-of-function mutations
of drk are homozygous lethal, but in the heterozygous
condition suppress the recruitment of multiple R7 cells in
flies with sev gain-of-function mutations. Furthermore, the
association of Drk with an activated form of Sev has
been demonstrated by both in vitro binding and co-
immunoprecipitation experiments. This interaction is
blocked by mutations that affect conserved residues of
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the Drk SH2 domain involved in phosphotyrosine binding
(Olivier et al., 1993).
Here we present the results of a combined biochemical
and genetic analysis of the sequences required for the
functional interactions between Sev and Drk and between
Drk and Sos. The Sev signalling pathway is particularly
well suited for this purpose because mutations in sev or
in drk can be analysed in vivo. Using a genetically
sensitized system, even small changes in the efficiency of
signal transduction can be detected. We show that a single
tyrosine residue in the C-terminal tail of the Sev protein
plays a central role in the binding of Drk and in mediating
efficient signalling by the Sev receptor. Furthermore, we
show that binding of Drk to Sos is mediated primarily by
the N-terminal SH3 domain and that there is comparatively
little contribution of the C-terminal SH3 domain to Drk
function.
Results
Tyr 2546 is essential for binding of Drk to Sev RTK
in vitro
In vitro studies have shown that the Drk SH2 domain
preferentially binds to the phosphopeptide motif pYXNX
(single amino acid code, where X can be any amino acid,
Songyang et al., 1994). Similar results have been obtained
for the Sem-5 and Grb2 SH2 domains (Songyang et al.,
1993, 1994). This motif is found only once in the cyto-
plasmic domain of the Sev protein, suggesting that this
site (Y2546ANE in the C-terminal tail of Sev; Basler and
Hafen, 1988) may represent an autophosphorylation site
that interacts with Drk. To test this hypothesis, we mutated
the corresponding codon in the sE-torso4021-sev transgene
which encodes a constitutively active Sev kinase. We have
previously shown that the fusion of the extracellular
domain of the mutant Torso4021 RTK carrying an activating
amino acid substitution in its extracellular domain
(Sprenger and Nuisslein-Volhard, 1992) with the Sev kinase
domain results in the strong constitutive activation of the
Sev kinase (Dickson et al., 1992). The transgene contains
the sev enhancer and the hsp70 heat-shock promoter. The
sev enhancer controls expression of the transgene in the
R7 equivalence group and hence permits analysis of the
encoded protein in the Sev pathway. The hsp70 heat-
shock promoter allows the ubiquitous expression of the
mutant protein in all cells of the fly providing sufficient
material for biochemical analysis. Several independent
transgenic lines were produced with this construct (sE-
torso4021-sevY2546F). An identical construct with the
K2242M mutation in the ATP binding site of the Sev kinase
domain was used as a negative control (sE-torso4021-
sevK2242M, Dickson et al., 1992).
To test the ability of the Torso402l_sevY2546F protein to
associate with Drk, we heat shocked flies carrying the sE-
torso4021_sev, the sE-torso402l-sevY2546F or the sE-
torso4021-sev K2242M transgenes for 45 min at 37°C to
induce ubiquitous expression of the transgenes and allowed
the flies to recover at room temperature for 3 h. Protein
extracts of these flies were then incubated with either anti-
Sev or anti-Drk antisera, and the chimeric Sev proteins
were identified in the anti-Sev and anti-Drk immunopre-
cipitates by immunoblotting with anti-Sev or anti-phospho-
tyrosine antibodies. Upon heat induction, all three
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Fig. 1. Binding of Drk to Sev and SevY2546F receptor tyrosine kinases
(A and B). Adult flies harbouring the sE-torso4021-sev, the mutant sE-
tOrso402 _sevY2546F or the kinase-defective sE-torso402lI_sevK2242M
transgenes were uninduced (-) or heat-shocked (+) and homogenized.
(A) Lysates of heat-shocked flies were immunoprecipitated with anti-
Sev sera and subjected to Western blot analysis with anti-Sev
antibodies to show the expression level of wild-type and mutant
chimeric Torso4021-sev proteins. Lysates were immunoprecipitated
with anti-Sev or anti-Drk antibodies, and the immune complexes were
subjected to Western blot analysis with anti-phosphotyrosine antibody
(B) or subjected to in vitro kinase reactions (C). (D) Phosphopeptide
inhibition of Drk association with Torso4021-sev. Lysates containing
Torso4021-sev were incubated with 2.5 ,ug of GST-Drk alone (lane 1)
or in the presence of increasing concentrations (0.1, 0.2, 0.5, 1, 10 and
20 gM), lanes 2-8, of the phosphopeptide pY2546
(KQLpYANEGVSR). 20 jM of the phosphopeptide
SSNpYMAPYDNY was used as a negative control, lane 9. After 90
min at 4°C, the beads were washed and associated Torso-sev was
identified by Western blot analysis with anti-phosphotyrosine
antibodies. The mobility of the Torso402l-sev protein is indicated.
Torso402l-sev chimeras accumulated to similar levels in
the different transformant lines (Figure I A). The Torso402 I_
sev receptor could be detected in anti-Drk immune com-
plexes, indicating that Torso402l-sev is associated with
Drk (Figure I B). However, neither the Torso40)2l-sevY2546F,
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nor the kinase-defective receptor were detectable in anti-
Drk immunoprecipitates.
To test the ability of the different Torso4021-sev proteins
to autophosphorylate, in vitro kinase reactions were per-
formed on anti-Sev and anti-Drk immune complexes
obtained from heat-shocked flies (Figure IC). Autophos-
phorylation of the Torso402l_sevY2546F receptor, precipit-
ated with anti-Sev antibodies, was reduced slightly
compared with the Torso4021-sev protein, while the
Torso402' sevK2242M mutant appeared incapable of
autophosphorylation. This indicates that the Torso4021-
sev Y2546F is active and that there are other major autophos-
phorylation sites in the Sev cytoplasmic domain. Consist-
ent with the results discussed above, only Torso4021-sev
was detected in anti-Drk immunoprecipitates using the
in vitro autokinase assay. Immunoblot analysis of the
in vitro kinase reactions with anti-Sev sera revealed that
approximately equal amounts of the different Torso4021-
sev chimeric proteins were made (data not shown).
To investigate whether autophosphorylation at Tyr2546
might create a direct binding site for the Drk SH2
domain, a synthetic phosphopeptide of 11 amino acids
(KQLpYANEGVSR) was synthesized that corresponds to
this region of the Sev tail. This pY2546 phosphopeptide
was used in a competition assay involving the binding of
the Torso4021-sev receptor to Drk. The pY2546 phospho-
peptide, at varying concentrations, was incubated along
with a GST-Drk fusion protein in the presence of protein
lysates from heat-shocked sE-torso4021-sev flies. Associa-
ted Torso4021-sev protein was identified by immuno-
blotting with anti-phosphotyrosine antibody. The pY2546
phosphopeptide inhibited the interaction of GST-Drk with
Torso4021-sev with an IC50 of -500 nM (Figure ID). In
contrast, a phosphopeptide (SSNpYMAPYDNY), corres-
ponding to the Tyr771 autophosphorylation site on the P
receptor for platelet-derived growth factor, at a concentra-
tion of 20 ,uM had no effect on the association of GST-
Drk with the activated Sev receptor. These results are
consistent with a model in which the association of Sev
with Drk is dependent on receptor autophosphorylation,
primarily at Tyr2546.
A mutation in Tyr2546 of Sev reduces but does
not eliminate Sev function in vivo
Given the dramatic effect of the Y2546F mutation on Drk
binding in vitro, we wanted to know whether this mutation
interferes with signalling from the Sev receptor in vivo.
Previously it was shown that the constitutive activation
of the Sev receptor under the control of the sev enhancer
results in the recruitment of additional R7 cells (Basler
et al., 1991; Dickson et al., 1992). The number of
additional R7 cells is a sensitive measure for the signalling
efficiency from the receptor. Flies that lack endogenous
sev gene function due to the sevd2 null allele but carry
one copy of the sE-torso4021-sev transgene have rough
eyes with multiple R7 cells per ommatidium (compare
Figure 2A, D and B, E). Flies carrying one copy of the
mutant sE-torso4021-sev Y2546F construct possess smooth
eyes (Figure 2C, F). To quantify the extent of the suppres-
sion caused by the Y2546F mutation, we counted the
number of R7 photoreceptor cells per ommatidium in
several independent transformant lines of the sE-torso4021-
sev and the sE-torso4021-sev Y2546F construct. Compared
with the transformants carrying the sE-torso4021-sev trans-
gene, which on average possess 3.8 + 1.0 (n= 128) R7
cells per ommatidium, the number of R7 cells is reduced
to an average of 0.3 + 0.3 (n=241) R7 cells per
ommatidium in the three sE-torso402' sev Y2546F trans-
formants lines analysed. Interestingly, the sev 2, sE-
torso4021_sevY2546F flies still contain some ommatidia with
one R7 cell (Figure 2F). Furthermore, flies carrying
two copies of the sE-torso4021-sevY2546F construct possess
rough eyes containing ommatidia with multiple R7 cells
similar to flies carrying a single copy of the unmutated
sE-torso4021-sev transgene (data not shown). This indicates
that the Torso402l_sevY2546F protein still retains residual
activity despite the lack of the putative Drk binding site.
Since the rough eye phenotype of sE-torso4021-sev is
caused by the transformation of the cone cell precursors
into R7 cells and not by the recruitment of the R7 precursor
itself, we wanted to test whether the same mutation also
prevents the specification of the R7 cell proper. To test
the effect of the Y2546F mutation in a sensitized system
for the R7 cell, we introduced the Y2546F mutation into
a transgene that encodes a partially functional Sev protein
carrying a mutation in the extracellular domain (sE-sev351,
B.D. and E.H., unpublished). In a sev mutant background,
flies homozygous for the transgene possess on average
0.81 + 0.06 (n=354) R7 cells per ommatidium. In
contrast, in flies carrying the identical construct with the
Y2546F mutation, the number of R7 cells is reduced to
0.03 + 0.04 (n=365). Therefore, this mutation reduces
the efficiency of signalling from Sev in all cells that can
adopt an R7 cell fate.
The N-terminal SH3 domain of Drk is required for
binding to the proline-rich C-terminus of Sos
Drk has been previously shown to associate in vitro with
the C-terminal proline-rich tail of Sos (Olivier et al., 1993;
Simon et al., 1993), and similar results have been obtained
for the mammalian proteins Grb2 and mSos 1 (Egan et al.,
1993; Li et al., 1993, Rozakis-Adcock et al., 1993). To
test whether both SH3 domains of Drk contribute equally
to binding of Sos, we mutated the highly conserved
tryptophan residue (W36A) in the N-terminal SH3 domain
or the analogous residue (W189A) in the C-terminal SH3
domain of Drk to alanine. Purified soluble wild-type Drk,
mutant DrkW36A or Drkwl89A proteins were tested for their
capacity to bind Sos fusion proteins immobilized on
agarose beads. For this analysis, residues 1225-1405 from
the C-terminal region of the Sos tail, including three
proline-rich motifs that are potential SH3 binding sites,
were expressed as a GST fusion protein (GST-Sos tail).
A distinct GST-Sos fusion protein (GST-SosN) containing
residues 505-692 from the amino-terminal region of Sos
was used as a control. Binding of wild-type or mutant
Drk to Sos was monitored by immunoblotting with anti-
Drk antibodies. Wild-type Drk bound specifically to the
Sos tail, but not to GST-SosN. Compared with wild-type
Drk, the W36A and W189A mutants were reduced in
their association with the Sos tail, on average by 85%
and 53%, respectively (Figure 3A). Similar results were
obtained using a filter binding assay, in which the GST-
Sos tail was immobilized on a filter and probed with wild-
type or mutant Drk proteins. In this assay, the W36A
mutant Drk protein failed to associate detectably with the
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Fig. 2. The sev gain-of-function phenotype of sE-torso4021-sev is suppressed by a mutation in the codon for the potential Drk binding site (Y2546).
Scanning electron micrographs and histological sections of wild-type (A, D), sE-torso4021_sev, (B, E) and sE-torso402J_sevY2546F (C, F) eyes. The sE-
torsVo402 '_sev flies possess rough eyes owing to the recruitment of multiple R7 cells (arrowheads in E). The number of R7 cells is greatly reduced in
flies expressing the sE-torso 01sev Y24Fconstruct (F). The experiments were carried out in a wv 18, seV"2 background. The scale bars represent
100 g.m in (C) and 10 gim in (F).
Sos tail, whereas W189A was reduced in its Sos binding
(data not shown). These results suggest that the more
N-terminal of the two Drk SH3 domains is primarily
responsible for the association of Drk with Sos.
We wanted to exclude the possibility that the observed
binding of the mutant Drk proteins was in part due to
residual activity of the SH3 domain carrying the Tmp to
Ala mutation. We therefore constructed two mutant Drk
proteins that entirely lack either the N-terminal SH3
domain [SH2-SH3(C)I or the C-terminal SH3 domain
[SH3(N)-SH2I. These truncated Drk proteins were pro-
duced in bacteria and analysed for their ability to bind
the Sos tail in a filter binding assay. Immobilized GST
protein alone was unable to bind to the wild-type Drk
protein (Figure 3B, lane 1). The mutant Drk protein
lacking the C-terminal SH3 domain bound in vitro to the
Sos tail with an efficiency approaching that of full-length
wild-type Drk protein (Figure 3B, lanes 2 and 3). In
contrast, the mutant Drk protein lacking the N-terminal
SH3 domain bound only very weakly to the Sos tail
(Figure 3B, lane 4). These results suggest that the N-
terminal SH3 domain is both necessary and sufficient for
efficient association with Sos in vitro.
Mutations in the SH3 domains of Drk impair 8ev
signal transduction to a different degree
The W36A and WI 89A substitutions in the Drk SH3
domains have distinct effects on Sos binding, suggesting
that the N- and C-terminal SH3 domains of Drk may not
be of equal functional importance. To test this hypothesis
in vivo, we placed the wild-type and mutant drk genes
under the control of the sev enhancer and the hsp7O heat-
shock promoter and generated transgenic flies (sE-drk; sE-
drkW36A ; sE-drkWJ89A). Protein expression of the different
transgenes was verified in a drk null mutant background.
Animals homozygous for the drkAP24 allele die as late
third instar larvae and show no detectable Drk protein on
Westem blots (Figure 4, lane 2). drkAP24 third instar larvae
carrying the different drk transgenes were heat shocked
to induce transgene expression, and analysed for the
presence of Drk protein by Westem blotting using an anti-
Drk antiserum. Upon heat induction, similar levels of Drk
protein accumulated in the transgenic strains expressing
either the wild-type (Figure 4, lane 3) or the mutant
proteins (Figure 4, lanes 4 and 5). Both the wild-type and
the mutant Drk proteins appear to be very stable. We did
not observe a substantial reduction in the amount of
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Fig. 3. Substitution of conserved residues in the SH3 domains of Drk
reduce the affinity for Sos. (A) GST-SosN and GST-Sos tail fusion
protein were expressed in bacteria and purified with glutathione-
agarose beads. Immobilized GST-SosN and GST-Sos tail were mixed
with 1, 0.5 or 0.25 .g of purified wild-type Drk, DrkW36A or
DrkwIs9A, incubated at 4°C for 90 min and washed. Complexes were
analysed by immunoblotting with anti-Drk antibodies. WT* designates
the negative control where GST-SosN was mixed with I ,ug of wild-
type Drk. The arrow indicates the mobility of Drk. (B) The N-terminal
SH3 domain of Drk is important for binding to the proline-rich Sos
tail. Purified GST (lane I) and GST-Sos tail fusion proteins (lanes 2-
4) were fractionated by SDS-PAGE and transferred to nitrocellulose.
The filter was then incubated with purified wild-type Drk (lane I and
2), or deletion mutants of Drk, SH3(N)-SH2 (lane 3) or SH2-SH3(C)
(lane 4) proteins. Binding of Drk and Drk mutants to the immobilized
GST-Sos fusion proteins was detected by immunoblotting with anti-
Drk antibodies. The Drk antiserum recognizes the various mutant
forms of Drk with comparable efficiency to the wild-type protein. An
arrow indicates the position of GST alone (lane I) and GST-Sos tail
(lanes 2-4).
protein even 16 h after the induction by heat shock (data
not shown).
To assay the function of the DrkW36A and DrkWl89A
mutant proteins in the Sev pathway, we tested their ability
to substitute for the function of the wild-type Drk protein
in a sE-torso4021-sev; drkRII+ background. The results of
this analysis are shown in Figure 5 and their quantification
is shown in Figure 5G. We have previously shown that
the removal of one copy of the endogenous drk gene
suppresses the rough eye phenotype caused by a constitu-
tively activated Sev RTK (Olivier et al., 1993). In sE-
torso4021-sev flies, 99% of the ommatidia contain multiple
R7 cells (Figure SA). Removal of one copy of drk reduces
the fraction of ommatidia with multiple R7 cells to 33%
(sE-torso4021-sev; drkRl/+, Figure SB). Expression of the
wild-type drk transgene in sE-torso4021-sev; drkRl/+; sE-
drk flies fully complements the suppression caused by the
drkRl mutation and restores this value to 95% (Figure 5C).
In contrast, only 22% of the ommatidia possess multiple
R7 cells in flies carrying the transgene that encodes a Drk
Fig. 4. Expression of drk under the control of the hsp7O promoter.
Third instar larvae of the following genotype were subjected to a I h
heat shock at 37°C: w118 (1); ,'/18; drkAP24/drkAP24 (2); w1118;
drkAP24/drkAP24; sE-drkW sE-drk (3); w1118; drkAI24/drI&W24; sE-
drkW36A/sE-drkw36A (4); w""118; drk_AP24/drkAP24; sE-drkW189A/sE-
drkW189A (5). After 4 h at 25°C lysates were prepared and Drk
expression was monitored by Western blotting with an anti-Drk
antiserum. Compared with wild-type larvae, high levels of Drk protein
are detected in all transgenic lines.
protein with a mutant N-terminal SH3 domain (Figure
5D). This suggests that this protein is unable to provide
normal Drk function. However, 78% of all ommatidia in
sE-torso4021-sev; drkRl/+ flies carrying the sE-DrkWJ89A
construct have more than one R7 cell (Figure SE), sug-
gesting the mutation in the C-terminal SH3 domain has
comparatively little effect on Drk function in the Sev
pathway. These results reflect the in vitro binding proper-
ties. Since even a Drk protein lacking the C-terminal SH3
domain was able to bind to the Sos tail we wanted to
verify that this protein was functional in vivo. In flies
carrying the sE-drkSH3(N)-SH2 transgene, 76% of the
ommatidia contain multiple R7 cells (Figure SF). Therefore
it appears that Drk can function in the Sev pathway even
in the complete absence of its C-terminal SH3 domain.
Drk is also required in other developmental pathways
(Simon et al., 1991; Doyle and Bishop, 1993; Diaz-
Benjumea and Hafen, 1994). The recessive lethality
associated with drk mutations is fully rescued by the
repeated ubiquitous induction of a wild-type drk cDNA
under the control of the hsp7O promoter (Olivier et al.,
1993). In contrast, neither the drkW36A nor the drkSH3(N)-
SH2 were able to rescue drk mutant flies. Only the drkWI89A
construct partially rescued drk homozygous mutant flies
(20% of the rescue ability of the wild-type drk transgene).
As in signalling downstream of the Sev RTK, the N-
terminal SH3 domain appears to be essential for Drk
function in other pathways. However, the fact that the
Drk protein lacking the C-terminal SH3 domain was
unable to rescue the lethality suggests that the C-terminal
SH3 domain has a more important function in these other
signalling pathways.
Drk binds to two proline-rich motifs in the
C-terminal tail of Sos
The C-terminal region of Sos contains three central proline-
rich motifs designated P1, P2 and P3, that might represent
SH3 binding sites (see Figure 6A). To test for a direct
interaction of Drk with these regions of Sos, GST fusion
proteins containing one or more of these proline-rich
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Fig. 5. Functional analysis of the SH3 domains in Drk in vivo.
Histological sections of the eyes of flies with the following genotypes are
shown: sE-torso4021-sev (A), sE-torso4021-sev, drkRl/+ (B), sE-
torso4021-sev, drkRl/+; sE-drk l+ (C), sE-torso1021-sev, drkRIl+; sE-
drkW36A/+ (D), sE-torso402t-sev, drkRl/+; sE-drkWJ89A/+ (E), sE-
torso4021-sev, drkRIl+; sE-DrkSH3(N)-SH21+ (F). The multiple R7 cell
phenotype of sE-torso4021-sev (A) is suppressed in flies heterozygous for
drkR1 (B). This suppression is reverted by expression of the wild-type drk
cDNA under the control of the sev enhancer (sE) (C). A single amino
acid exchange in the N-terminal SH3 domain (W36A) of Drk prevents
the rescue ability (D), whereas the corresponding substitution in or the
complete removal of the C-terminal SH3 domain have little effect on Drk
function (E and F). A quantification of the results presented in A-F are
shown in (G). The bars represent the percentage of ommatidia containing
more than one R7 cell. For each construct, two heads of two independent
transformant lines were sectioned and the ommatidia counted. The scale
bar in (F) represents 10 pm.
sequences were prepared. One of these fusion proteins
(GST-Sos P1-P3) contains the entire region spanning the
P1-P3 sites (residues 1313-1387), while others contain
1400800 800
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Fig. 6. Concentration dependence of Drk binding to truncated GST-
Sos fusion proteins. (A) Schematic diagram illustrating the structural
domains of Sos. The N-terminus (white box) of Sos contains a Dbl
homology domain and a PH domain. The Cdc25 domain is likely to
function as the catalytic domain with guanine nucleotide exchange
activity. The C-terminus is proline-rich with three motifs labelled P1-
P3 that resemble potential SH3 binding sites. Purified Drk protein, at
concentrations of 0, 50, 100, 200, 300, 400, 500, 600, 750, 1000 and
1250 pM (lanes 1-11) was incubated with a volume of bacterial lysate
containing -300 nM of (B) GST-Sos P1-P3 or GST alone (lane 12)
or (C) GST-Sos P3 in I ml PLC lysis buffer for 2 h at 4°C.
Glutathione-agarose beads were added to the mixture, and the
incubation continued for 20 min. The beads were washed, and bound
proteins were resolved by 15% SDS-PAGE and detected by
Coomassie Blue staining. (D) Graph of Drk band intensity, as
determined by optical densitometry, as a function of the initial Drk
concentration. Filled and open circles represent Drk binding to GST-
Sos Pl-P3 and GST-Sos P3, respectively.
individual proline-rich motifs. For example, GST-Sos P3
contains residues 1353-1387, spanning the P3 site. These
GST-Sos fusion proteins were immobilized on gluta-
thione-Sepharose beads and tested for their ability to bind
soluble Drk protein. Whereas no Drk was precipitated in
control experiments using GST alone, each of the GST-
Sos fusion proteins bound Drk. Furthermore, when tested
at approximately equivalent molar concentrations, the
T.Raabe et al
A
B
C
Ws
wmt 7w
#cs,b
Fisv^w .. v w ^ ^- < iq~~~~~~~~.................
F J i'.
2514
___
__w_-_
_
"SvI
0.1", 'r.,m Iiz. 9.
.l.. .4? 'I NMI1111, I "'
Drosophila Drk SH2/SH3 adaptor protein
GST-Sos fusion proteins containing multiple proline-rich
sequences appeared to bind more Drk than fusions with
individual proline-rich motifs. This is illustrated in Figure
6, where concentrations of purified Drk ranging from 50
to 1250 nM were tested for binding to -300 nM of GST-
Sos Pl-P3 fusion protein (Figure 6B). This is compared
with the result obtained using 300 nM of a fusion protein
containing a single motif, GST-Sos P3 (Figure 6C), and
to GST alone. Optical densitometry of the Coomassie
Blue-stained Drk band revealed that almost four times
more Drk was bound to the construct containing multiple
proline-rich motifs (Figure 6D).
To further delineate the likely contact points on Sos for
the Drk SH3 domain, synthetic peptides corresponding to
three proline-rich motifs within the region of Sos shown
to interact directly with Drk were synthesized, and
employed in competition experiments. In these studies,
the peptides, at concentrations from 70 to 700 nM, were
incubated in a solution containing 600 nM Drk and
300 nM GST-Sos P1-P3 fusion protein for 90 min at
4°C. Following this period, excess GST beads were added
and the mixture allowed to incubate for a further 30 min
After washing, the beads were analysed for the amount
of Drk present and compared with a control where no
peptide was added. As shown in Figure 7A, two of
the peptides displayed inhibitory properties. Peptide P1,
sequence YRAVPPPLPPRR, showed the strongest inhibi-
tion, IC50=50 ,uM; while P2, sequence GELSPPPIPPRL,
was poorer, IC50 = 280,M (Figure 7B). The third peptide,
P3, sequence GAPDAPTLPPRD, showed little inhibition.
Taken together, these results indicate that the N-terminal
Drk SH3 domain is principally responsible for the binding
of Drk to Sos. Furthermore, analysis of potential SH3
binding sites has defined specific proline-rich motifs in
the Sos tail that can associate with Drk in vitro. The
highest affinity site is represented by the peptide
YRAVPPPLPPRR. However, Sos polypeptides containing
multiple proline-rich motifs apparently bound Drk more
efficiently than proteins with single proline-rich motifs.
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Fig. 7. (A) Peptide competition of Drk binding to truncated GST-Sos
PI-P3 fusion protein. Approximately 600 nM of purified Drk protein
were incubated with bacterial lysates containing 300 nM GST-Sos
P1-P3 fusion protein in the presence of proline-rich peptides P1
(YRAVPPPLPPRR), P2 (GELSPPPIPPRL) and P3
(GAPDAPTLPPRD), at concentrations of 70, 172, 343, 515 and
686 ,uM, lanes 1-5, 128, 256, 384 and 512 ,uM, lanes 6-9 and 136,
273, 409 and 545 ,uM, lanes 10-13. No peptide was added as a control
in lane 14. Following a 90 min incubation period at 4°C, glutathione-
agarose beads were added and the incubation continued for 30 min.
The beads were washed, and bound proteins resolved by 15% SDS-
PAGE and detected by Coomassie Blue staining. (B) The magnitude of
peptide inhibition, monitored relative to a control with no peptide
added, was determined from the intensity of the Drk band estimated
by optical densitometry, plotted in a graph as a function of peptide
concentration. * = peptide P1; A = peptide P2; * = peptide P3.
Discussion
In this study we have combined biochemical and genetic
assays to investigate the functional interactions between
the Sev receptor tyrosine kinase, the SH2/SH3 adaptor
Drk and the guanine nucleotide exchange factor Sos.
Sev-Drk interactions
The only sequence in the Sev cytoplasmic domain that
fits the YXNX binding consensus for Sem-5-type SH2
domains (Songyang et al., 1993, 1994) is the sequence
Y(2546)ANE in the C-terminal tail of the Sev receptor.
Substitution of Tyr2546 with Phe results in a lower degree
of Sev autophosphorylation (Figure 1), and loss of binding
to Drk. Furthermore, the binding of Drk to Sev can be
competed with a phosphopeptide corresponding to the C-
terminal tail of Sev containing Tyr2546. These results
suggest that Tyr2546 is an autophosphorylation site
required for binding of the Drk SH2 domain. Since these
experiments have been carried out in fly extracts we
cannot rule out that the binding of Drk to Sev is indirect
via another protein. The functional significance of Tyr2546
is supported by our in vivo experiments. Introducing the
Y2546F substitution into a constitutively active form
of the Sev receptor or a partially functional receptor
significantly impairs the specification of the R7 cell fate
in the R7 equivalence group (Figure 2).
Given the dramatic effect of the Y2546F mutation on
the binding of activated Sev to Drk, it is surprising,
however, that this mutation does not completely abolish
the ability of Sev to specify R7 cells. Since these experi-
ments have been carried out in a sev null mutant back-
ground, the only source of Sev protein is the mutant
Torso402l_sevY2546F or the partially functional Sev351 recep-
tor containing the Y2546F substitution, respectively. In
each case R7 cells can still form, albeit at a lower
frequency. Furthermore, rescue experiments with a
genomic DNA fragment encompassing the entire sev gene
in which this Y2546F mutation had been introduced
showed that this mutant sev gene could completely rescue
the sev mutant phenotype (K.Basler, C.Bierkamp and E.H.,
unpublished data). This indicates that the levels of Sev
activity in the R7 precursor cell containing a wild-type
Sev receptor are sufficient to specify R7 cell development
even in the absence of the Y2546 autophosphorylation
site. In either a seV351 or a sE-torso4021-sev background,
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however, the Sev activity is at a critical threshold where
the Y2546F mutation has a dramatic effect on the efficiency
of R7 cell specification.
There are at least three possibilities to explain how Sev
signalling can occur in the absence of the putative Drk
binding site. (i) Drk is able to bind the phosphorylated
Sev receptor at other low affinity sites. (ii) Drk binds Sev
indirectly via another protein. (iii) Sev can signal in a
Drk-independent parallel pathway. The absence of addi-
tional SH2 binding consensus sequences for the Drk/Grb2/
Sem-5-type SH2 domains in the cytoplasmic domain of
Sev, together with the complete failure to immuno-
precipitate the mutant Sev protein with the anti-Drk
antiserum, makes the first explanation unlikely. From
biochemical studies on vertebrate RTKs there are pre-
cedents for the second and the third possibilities. It has
been shown that the tyrosine phosphorylation of proteins
such as Shc, IRS- 1 and Syp at YXNX motifs can create
binding sites for Grb2 (Pelicci et al., 1992; Rozakis-
Adcock et al., 1992; Baltensperger et al., 1993; Feng
et al., 1993; Pronk et al., 1993; Skolnik et al., 1993a,b;
Vogel et al., 1993, Li et al., 1994). While both Shc and
Syp have SH2 domains, Shc can also bind to activated
receptors in an SH2 domain-independent way through its
PTB domain (Blaikie et al., 1994; Kavanaugh and
Williams, 1994). IRS- I lacks an SH2 domain, but interacts
with the juxtamembrane region of the insulin receptor.
The Syp homologue Corkscrew (Csw) in Drosophila may
similarly act as an intermediate between Sev and Drk.
Genetic evidence for a role of Csw in the Sev pathway
has been obtained. Mutations in csw have been shown to
impair signalling in the Torso and Sev pathways (Simon
et al., 1991; Perkins et al., 1992; M.Simon personal
communication). It is interesting to note that the Grb2
binding site, pYTNI in Syp (Bennett et al., 1994), is
perfectly conserved in Csw. There is, however, no direct
evidence yet that Csw interacts with, or is a substrate for,
the Sev receptor.
Evidence of the third possibility that RTK signalling
occurs via a parallel Drk-independent parallel pathway,
has also been obtained from vertebrates. It has been shown
that activated RTKs can associate with and phosphorylate
a number of SH2 domain-containing proteins, several of
which can potentially activate the Ras pathway (Koch
et al. 1991; Pawson and Schlessinger, 1993; Valius and
Kazlauskas, 1993). For the colony-stimulating factor 1
(CSF- 1) receptor it has been shown that only the combined
mutation of Grb2 and phosphoinositol-3 (PI-3) kinase
binding sites completely abrogates signal transduction,
whereas mutation of either binding site alone reduced the
ability to change morphology or growth rate in response
to CSF-1 stimulation (van der Geer and Hunter, 1993).
So far, there is no evidence for an involvement of PI-3
kinase in Sev-mediated signal transduction in Drosophila.
The existence of a Drk-independent pathway is suggested,
however, by the analysis of drk homozygous mutant cell
clones in the eye or in the adult cuticle. The phenotypes
of the strongest Drk alleles are less severe than those
observed in clones of other mutations in the pathway,
such as Raf, Rasl or the corresponding receptors (Simon
et al., 1991; Diaz-Benjumea and Hafen, 1994). Although
a residual Drk function in the alleles tested could explain
the different strength in phenotypes, we think this is
unlikely since both alleles tested result in the substitution
of conserved amino acids in the SH2 domain which
completely abolish SH2 binding in vitro (Olivier et al.,
1993). Furthermore, the Drk alleles tested exhibit the same
degree of suppression of sE-torso 4021-sev as the drk null
allele, drkAP24. We therefore consider it quite likely that a
parallel, Drk-independent pathway leading to the activation
of Ras I and Raf exists. It is possible that mutations in
genes coding for components in this pathway have not
been identified because these components are not rate
limiting for Sev signalling in the presence of Drk.
The interaction between Drk and Sos is mediated
primarily via the N-terminal SH3 domain
In vitro binding studies indicated that a mutant Drk protein
carrying a substitution of a conserved Trp (W189) to Ala
in the C-terminal SH3 domain bound to Sos peptides with
similar efficiency to the wild-type protein. W36 and WI 89
in Drk are residues that are invariably conserved in all
known SH3 domains and are part of the peptide binding
pocket (Koyama et al., 1993). Furthermore, a truncated
Drk protein that completely lacks the C-terminal SH3
domain is still able to bind to Sos, albeit with reduced
efficiency. The results obtained in vitro correlate well with
the results of our in vivo analysis of the Drk SH3 domains.
Constructs encoding either the DrkwI89A protein or a Drk
protein completely lacking the C-terminal SH3 domain
were able to largely rescue the dominant suppression of
the rough eye phenotype of sE-torso4021-sev by drk null
mutations. However, Drk with the substitution of the
analogous residue in the N-terminal SH3 domain failed
to bind efficiently to the Sos tail and was unable to rescue
the suppression by drk of sE-torso4021-sev. Therefore, the
N-terminal SH3 domain is necessary and sufficient for
efficient binding of Drk to Sos in vitro, and for efficient
signal transduction from the Sev kinase in vivo.
Recent structural analysis has shown that the N- and
C-terminal SH3 domains of Sem-5 and Grb2 bind to
proline-rich peptides in the opposite orientation (i.e. C-
to N-terminal) compared with previously observed SH3
complexes (Feng et al., 1994; Lim et al., 1994; Wittekind
et al., 1994) These Sem-5/Grb2 binding peptides contain
the sequence NH2 X-P-p-X-P-p-R COOH where X is an
aliphatic residue, p is a scaffolding residue (often a proline)
that maintains the polyproline type II helix, and the C-
terminal arginine forms a salt bridge with an acidic SH3
domain residue. Additional C-terminal arginines appear
to increase the binding affinity (Feng et al., 1994). The
high affinity binding site for Drk on Drosophila Sos,
represented by the P1 peptide YRAVPPPLPPRR, conforms
to this consensus. The aliphatic-proline pairs (P-P; L-P)
probably fit into the hydrophobic binding pockets on the
Drk N-terminal SH3 domain, while the underlined arginine
potentially makes a salt bridge with Glu16 (Lim et al.,
1994; Wittekind et al., 1994). Our data suggest that the
N-terminal Drk SH3 domain is primarily responsible for
binding to Sos, and may contact the YRAVPPPLPPRR
(P1) site in the Sos tail.
The in vitro binding studies suggest that the C-terminal
SH3 domain enhances the binding of the N-terminal SH3
domain to Sos. The wild-type form of Drk binds more
strongly to the Sos tail than either DrkwI19A or the C-
terminally truncated Drk. Similarly, the drk transgenes
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with a mutation or a deletion in the C-terminal SH3
domain are somewhat less efficient in rescuing the drk
function than the wild-type gene. It is therefore likely that
the C-terminal SH3 domain of Drk strengthens the Drk-
Sos interaction by interacting with a second proline-rich
sequence, such as the P2 sequence, upon binding of the
N-terminal SH3 domain to the PI sequence. The C-
terminal Drk SH3 domain might also play a role distinct
from binding to Sos. It has also been shown that both
SH3 domains of Grb2 interact with Dynamin, a GTPase
that functions in endocytosis and synaptic transmission
(Gout et al., 1993; Scaife et al., 1994). The C-terminal
SH3 domain may similarly be involved in coupling Drk
to other proteins that do not play a major role in Sev
signalling. A more central role of the C-terminal SH3
domain of Drk in other signalling pathways is suggested
by our observation that the Drk construct lacking the C-
terminal SH3 domain was unable to rescue the lethality
associated with drk mutations, whereas the same construct
functioned to near normal levels in the Sev pathway.
Finally, this paper illustrates the importance of utilizing
both in vitro assays and a sensitive in vivo analysis
to decipher the functional importance of the individual
domains of Drk. By applying both of these approaches
we were able to identify a site in Sev required for
association with Drk, to define contact sites between the
Drk SH3 domains and Sos and to test the importance of
these interactions in vivo.
Materials and methods
Genetics
Mutations in the drk gene were isolated in a genetic screen for second-
site modifiers of the rough eye phenotype of the gain-of-function
mutation SevS11 which encodes a constitutively activated Sev protein
(Basler et al., 1991; Olivier et al., 1993; T.R. and E.H., unpublished
data). All experiments were performed in a sev1'2 null mutant background
(Basler et al., 1991). Loss-of-function mutations in the drk gene lacking
detectable levels of Drk protein were generated by mobilizing the P-
element insertion drkP24 using a stable source of transposase (Robertson
et al., 1988). Based on the suppression of the torso4021-sev rough eye
phenotype, non-complementation of existing drk alleles and the absence
of Drk protein on Western blots (see Results), drkAP24 was designated
as a complete loss-of-function mutation. For the experiments described
in Figure 5, transgenic lines carrying the different drk constructs were
crossed to it, 8, sev12 flies bearing the drkRl mutation and the sE-
torso 402l_sev transgene on the same chromosome. To test whether
ubiquitous expression of the drk constructs could rescue the lethality of
drk mutations, we crossed drYAP24/Bc Gla flies with dr5AP24/Bc Gla flies
homozygous for the sE-drk"'I, sE-drkU-16A or sE-drkVIW89A, respectively.
The temperature was shifted to 37°C for 60 min every 8 h throughout
development. These mutant constructs behaved identically in independent
rescue experiments with drkRlIdrkE(se'v2B flies (data not shown). The
rescue ability of the drkSH3(N)-SH2 construct lacking the C-terminal SH3
domain was tested in a cross of drkR /Sco flies with drkEev)2B/CvO;
drkSH3(N)-SH2/+ using the same temperature treatment. Whereas the
expected number of drkRl/drkE(ev2B; .sE-drk-'±+ flies were obtained in
the control experiment (79/305 flies carrying the sE-drkVi' construct), no
drkRl/drk'E(se)2B; sE-drkSH3(,V)SH2/+ flies survived (0/10)7).
Plasmid construction for germline transformations
The torso402_-sev and torso4021_sev,K2242M constructs are described in
Dickson et al. (1992). The Y2546F substitution was introduced into
torso4021-sev by replacing a 1.1 kb BamHI cDNA fragment with the
corresponding fragment from a set cDNA in which the Y2546 codon
has been mutated by site-directed mutagenesis. The hypomorphic set
construct, .sei-31, in which the codons for Y1485 and W1486 in the
extracellular domain of Sev have both been replaced by alanine codons,
was generated in the course of a structure-function analysis of the Sev
extracellular domain (B.D. and E.H., unpublished data). The W36A and
W189A Drk mutations were generated by site-directed mutagenesis of
the drk cDNA using the oligonucleotides GGAAGACGATFCAAATGC-
ATATCGCGCGGAGC and GCTCCGATGAGAACGCGTGGAACGG-
CGAG, respectively. For germline transformations a modified pW8
transformation vector was used (Klemenz et al., 1987). All derivatives
of the original torso4021-sev! and drk constructs are under the control of
a single copy of the 1.2 set enhancer fragment and the hsp70 promoter
(sE). Expression of the partially functional sei-VS and sel351-Y2546F
receptors is driven by a duplicated sev enhancer (Basler et al., 1991).
Transgenic lines were generated by injection of Quiagen purified plasmid
DNA into wu/ 58sev'12 or IIM8 embryos as described previously (Basler
et al., 1991). For all constructs, several independent transformant lines
were established.
Scanning electron microscopy and histology
Adult flies for scanning microscopy were stored in 70% acetone before
they were critical-point dried and coated for examination with a Hitachi
S-4000 scanning electron microscope. The preparation of histological
sections has been described previously (Basler and Hafen, 1988).
Western blotting and immunoprecipitation
For immunoprecipitations, adult flies were homogenized in PLC-LB
[50 mM HEPES (pH 7.5), 150 mM sodium chloride, 10% glycerol, 1%
Triton X-100, 1.5 mM MgClI I mM EGTA, 100 mM NaF and 10 mM
NaPPi] containing 1 mM sodium orthovanadate and I mM phenylmethyl-
sulphonyl fluoride. Lysates were clarified by centrifugation and incubated
with 2 ,ug/ml affinity-purified anti-Drk or 1:200 dilution of anti-Sev, and
protein A-Sepharose, for 90 min at 4°C. Immunoprecipitates were
washed three times with I ml HNTG [20 mM HEPES (pH 7.5), 150 mM
sodium chloride, 10% glycerol, 0.1I% Triton X-100 and 1 mM sodium
orthovanadatel, and then boiled for 5 min in SDS sample buffer. All
samples were fractionated by electrophoresis on 8.25%, or 10% SDS-
polyacrylamide gels, and transferred to nitrocellulose in a semi-dry
blotting apparatus at 0.8 mA/cm2 for I h. Filters were blocked for I h
at room temperature in 5% non-fat dry milk in TBS-T [20 mM Tris
(pH 7.5), 150 mM sodium chloride, and 0.05% Triton X-I001 and probed
with 2 jtg/ml affinity-purified anti-Drk, or 1:1000 dilution of anti-Sev.
The anti-Drk antiserum was generated in a rabbit against a non-GST-
Drk fusion protein (Olivier et al., 1993). The anti-Sev antiserum (G24)
was generated in a goat against a bacterially synthesized protein
corresponding to cytoplasmic kinase domains of Sev. For anti-phospho-
tyrosine immunoblots, filters were blocked in 5% bovine serum albumin
(BSA), 1% ovalbumin in TBS-T and probed with I ,ug/ml affinity-
purified anti-phosphotyrosine antibodies as described previously (Letwin
et al., 1988). Anti-Drk and anti-Sev immunoblots were developed using
either the ECL kit (Amersham), or [12511protein A (Amersham). The
anti-phosphotyrosine immunoblots were processed using l125lJprotein A.
GST fusion proteins
Drk was amplified by polymerase chain reaction (PCR) and subcloned
into the bacterial expression plasmid pGEX-KT (Pharmacia) as described
previously (Olivier et al. 1993). The drkW36A and drk""'89A mutants were
produced by PCR and subcloned into pGEX-KT. The deletion mutants
of Drk, SH3(N)-SH2 (amino acids 1-156) and SH2-SH3(C) (amino
acids 60-211) were amplified by PCR and subcloned into pGEX-KT.
Four regions of Sos were amplified by PCR and subcloned into the
pGEX-KT vector; pGEX Sos-N encodes amino acids 505-692, pGEX
Sos-tail amino acids 1225-1405, pGEX Sos Pl-P3 amino acids 1313-
1387, and pGEX Sos P3 amino acids 1353-1387. All plasmid constructs
were sequenced using the Sequenase method (United States Biochemical
Corporation) and transformed into Escherichia coli DHS5X. Bacteria were
grown to an OD600 of 0.6 and fusion proteins were induced at 30°C
with I mM isopropyl-f-D-thiogalactosidase (IPTG) for 3 h. Cells were
collected, sonicated in PBS-T2 (PBS, 1% Triton X-100 and 1% Tween)
and clarified by centrifugation. The supernatant was incubated with
glutathione-agarose beads for I h at 4°C and washed three times with
PBS-T'.
In vitro binding studies
Adult flies were lysed in PLC lysis buffer at 10 flies per ml of buffer,
the homogenate was cleared by centrifugation and incubated with
immobilized GST or GST fusion proteins (2.5 ,ug) for 90 min at 4°C.
All complexes were washed three times with HNTG, boiled for 5 min
in SDS sample buffer, resolved by SDS-PAGE (8.25%) and transferred to
nitrocellulose. Filters were blocked and probed with anti-phosphotyrosine
antibodies as described above. Protein complexes were also subjected
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to in vitro kinase assays. Both immune complexes and GST fusion
protein complexes were incubated with 0.5 jCi of [,y-32P]ATP in KRB
120mM HEPES (pH 7.4), 25 mM magnesium chloride, 4 mM manganous
chloride and 0.1 mM sodium orthovanadate] at room temperature for 15
min. Reactions were stopped by adding an equal volume of 2X SDS
sample buffer. A fraction of the kinase reaction was separated by SDS-
PAGE and the gel was fixed, dried and exposed to film.
GST-SosN and GST-Sos tail fusion proteins were expressed in
bacteria and purified with glutathione-agarose beads. Immobilized GST-
SosN and GST-Sos tail were mixed with I gg, 0.5 gg or 0.25 .tg of
purified wild-type Drk, DrkW36A or DrkwI89A and incubated for 90 min
at 4°C. Complexes were washed three times with HNTG, boiled for 5
min in SDS sample buffer, resolved by SDS-PAGE (10%) and transferred
to nitrocellulose. Filters were blocked and immunoblotted with anti-Drk
antibodies and processed using [1251]protein A. The amount of Drk was
quantified using a Phosphorlmager (Molecular Dynamics).
Purified GST, GST-SosN and GST-Sos tail bacterial fusion proteins,
I ,ug of each, were resolved by 10% SDS-PAGE and were transferred
to nitrocellulose. Filters were blocked in TBS containing 5% BSA, 1%
ovalbumin and 0.1% SDS overnight at 4°C. These filters were probed
using purified wild-type or mutant Drk protein from bacteria for 3 h at
room temperature at I sg/ml and washed three times with TBS + 0. I%
SDS. Complexes were detected by immunoblotting using affinity-purified
anti-Drk antibodies in 5% BSA, 1% ovalbumin in TBS and processed
with [ 12511protein A.
To determine the concentration dependence of Drk binding to truncated
GST-Sos fusion proteins, purified Drk protein, at concentrations of 0,
50, 100, 200, 300, 400, 500, 600, 750, 1000 and 1250 ,uM, was incubated
with a volume of bacterial lysate containing -300 nM of GST-Sos P1-
P3, GST-Sos P3, or GST in I ml PLC lysis buffer for 2 h at 4°C. Forty
,ul of 50% (v/v) glutathione-agarose beads were added and the incubation
continued for 20 min. Following three 1 ml PLC lysis buffer washes of
the beads, bound proteins were resolved by 15% SDS-PAGE and
detected by Coomassie Blue staining.
Peptide competition
The phosphopeptide pY2546 (KQLpYANEGVSR) was added to lysates
containing Torso-sev, to final concentrations of 20, 10, 1, 0.5, 0.2 and
0.1 ,uM in the presence of 2.5 ,ug immobilized GST-Drk fusion
protein and incubated for 90 min at 4°C. As a control, non-specific
phosphopeptide pY771 (SSNpYMAPYDNY) was also used at 20 tM.
All complexes were washed three times with HNTG, boiled for 5 min
in SDS sample buffer, resolved by SDS-PAGE (8.25%) and transferred to
nitrocellulose. Filters were blocked and probed with anti-phosphotyrosine
antibodies as described above and quantified using a Phosphorlmager
(Molecular Dynamics).
Peptide competition of Drk binding to truncted GST-Sos
Pl-P3 fusion proteins
Approximately 600 nM of purified Drk protein was incubated with
bacterial lysates containing 300 nM GST-Sos PI-P3 fusion protein
in the presence of proline-rich peptides P1 (YRAVPPPLPPRR), P2
(GELSPPPIPPRL) and P3 (GAPDAPTLPPRD), at concentrations ran-
ging from 70 to 700 gM (see Figure 7). Following a 90 min incubation
period at 4°C, 40 ml of 50% (v/v) glutathione-agarose beads was added
and the incubation continued for a further 30 min. The beads were
washed with three 1 ml volumes of PLC lysis buffer, bound proteins
resolved by 15% SDS-PAGE and detected by Coomassie Blue staining.
The magnitude of peptide inhibition, monitored relative to a control with
no peptide added, was determined from the intensity of the Drk band
estimated by optical densitometry, plotted in a graph as a function of
peptide concentration.
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